Protalix BioTherapeutics (PLX) Tax Rate (2023 - 2026)

Protalix BioTherapeutics has reported Tax Rate for 4 years, with the latest figure at 13.02% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate rose 999.0% year-over-year to 13.02%; the trailing twelve-month figure through Mar 2026 stood at 16.8% (up 151.0% YoY), and the FY2025 full-year result was 14.33%, down 2837.0% from the prior year.
• Tax Rate for Q1 2026 stood at 13.02%, up from 15.08% in the prior quarter.
• The five-year high for Tax Rate was 40.24% in Q2 2025, with the low at 15.08% in Q4 2025.
• Average Tax Rate over 4 years is 4.22%, with a median of 3.03% recorded in 2025.
• Peak annual rise in Tax Rate reached 3721 bps in 2025, while the deepest fall reached 2400 bps in 2025.
• Tracing PLX's Tax Rate over 4 years: stood at 12.29% in 2023, then soared by 173 bps to 8.92% in 2024, then plunged by 269 bps to 15.08% in 2025, then surged by 186 bps to 13.02% in 2026.
• The last three Tax Rate figures came in at 13.02% (Q1 2026), 15.08% (Q4 2025), and 7.82% (Q3 2025), per Business Quant data.

Peer Comparison